Category Archives: Stem Cell Therapy

Madison #39;s Before After Stem Cell Therapy
Had step cell therapy procedure on 4/14/14 and we were seeing noticeable results only 4 short days later.

By: Jaie Locke

Continued here:
Madison's Before & After Stem Cell Therapy - Video

stem cell therapy treatment for cerebral palsy with mental retardation with low vision by dr alok
improvement seen in just 3 months after stem cell therapy treatment for cerebral palsy with mental retardation with low vision by dr alok sharma, mumbai, ind...

By: Neurogen Brain and Spine Institute

More here:
stem cell therapy treatment for cerebral palsy with mental retardation with low vision by dr alok - Video

MANILA - A businessman has updated the charges he filed with the National Bureau of Investigation (NBI) against a wellness center operator who allegedly caused the death of his daughter, a cum laude graduate of Ateneo de Manila University, last year.

Bernard Tan added the illegal practice of medicine to the charges of estafa and reckless imprudence resulting in homicide he filed in October 2013 against Antonia Carandang-Park, her husband Young Joe Park and some center personnel over the death of his daughter Katherine Grace, 23, on July 4, 2013.

Tan based the additional charge on a certification issued in August 2013 by the Professional Regulation Commission showing that Park does not appear in the database of physicians, which contains the names of those duly authorized to practice medicine in the Philippines.

In an interview, Tan said Kate allegedly underwent stem cell treatment for Hodgkins lymphoma, a type of cancer, at the Green and Young Health and Wellness Center owned by Park in Tagaytay City during the last quarter of 2012.

We went to her clinic and she told us that she already treated a similar case and it would only take three months to treat my daughter We did not know that she is not a doctor, he said.

According to Tan, his daughter was in remission but she no longer wanted to undergo the pain of cancer treatments like chemotherapy and radiation.

She also did not want to miss classes because she was graduating cum laude in March 2013. So when we heard about Park, we went to her clinic in Tagaytay, he said.

Tan said Park had promised his family that she could cure Kate within three months, provided that she will not receive any complimentary treatment from other doctors. She assured the family that she already treated a similar case in the past.

Tan said Park had injected embryonic stem cells into his daughter several times and Kate was fed only bananas and vegetable juices for three months.

Three months passed but my daughters condition was not improving. She started to lose weight. She was deteriorating so we brought her to (conventional doctors), he said.

Read the original:
Stem cell 'doctor' faces more raps for Ateneo grad's death

Sweet Science Lesson! See How Stem Cell Therapy Works
http://www.innovationsstemcellcenter.com Call: 214.420.7970 Facebook: https://www.facebook.com/innovationsmedical Twitter: https://twitter.com/dallasdrj Instagram: http://instagram.com/drbilljo...

By: dallasdrj

Read the original here:
Sweet Science Lesson! See How Stem Cell Therapy Works - Video

PALMYRA -- Gunny, an 8-year-old German shepherd, who has been suffering from painful arthritis in his hips, got a new lease on life Wednesday after receiving an injection of stem cells from his own body.

Gunny was the first of two dogs with degenerative joint disease who were treated with a new, faster and less expensive procedure at the Palmyra Animal Clinic, 920 E. Main St. The new process, which is available for dogs, cats and horses, uses stem cells taken from fatty tissue in the animals to combat osteoarthritis to improve their quality of life.

The process has been around for a decade, but with new technology, the local clinic is able to do the process in-house, in less time and at less cost. The clinic has been offering stem cell therapy since 2008.

While stem cell therapy has been commercially available for about a decade, Dr. Calvin Clements, owner of the clinic, said, "there was a several-day turnaround, multiple anesthesias, and it was considerable expense. With this technique, we have the ability to collect the cells, inject the cells and bank the cells."

The cost of the procedure is about $1,300, compared to $3,000 when sent out of house, Clements said.

On mobile? Click here to view photo gallery

On Wednesday, Clements and his associate, Dr. Richard Hann, used the new process - known as Adipose-Derived Stem Cell Procedure - for the first time in their office with Gunny, and Hudson, an 8-year-old toy fox terrier, who has arthritis in his knees.

Clements said an animal's pain from degenerative disease is similar to humans.

"Like the pain that anyone who has advanced joint degenerative disease experiences, at first, it doesn't hurt too bad but as time progresses some are in considerable pain. It can be very severe," he said.

"We're looking to improve their joint function. Stem cell therapy has really proven itself just by the outcome that we've had in patients when we were shipping it out," Clements said. "This is more convenient. It's a faster process. It's in-house, and we know how the samples are being handled from beginning to end."

Link:
Palmyra Animal Clinic adds new stem cell therapy to improve animals' lives

St. Petersburg, FL (PRWEB) April 17, 2014

One of the most respected plastic surgeons in America is encouraging the FDA to move forward on approval of stem-cell based therapies inspired in part by Matthew McConaughey's recent Oscar win for the film Dallas Buyers Club. In the film, McConaughey portrayed Ron Woodroof, who fought the Food and Drug Administration over his use and distribution of unapproved but effective HIV/AIDS medications. In a letter to FDA comissioner Margaret A. Hamburg dated April 14th, Dr. Christian Drehsen of St. Petersburg claims that the story echoes current FDA treatment of stem cell therapies, of which almost none are approved for use in the United States.

Drehsen cites his extensive past experience working with stem cells, and calls on the FDA to provide more rapid approval for the procedures, which he says are safe and effective.

In the period 2009-2010, before the current regulatory embargo, Drehsen performed over 20 reconstructive and cosmetic stem-cell procedures using technology from the pioneering stem cell therapy research firm Cytori. In his letter, Drehsen writes that the results of his procedures were excellent, and hes frustrated with the limitations now in place.

Japan has approved these procedures. Much of Europe has approved them. Theyre changing peoples lives every day but not in the United States, the letter reads in part.

Stem cell therapies have myriad potential uses. Drehsen says that in his own practice at the Clinique of Plastic Surgery, their promise includes greatly improved outcomes for burn victims, patients with extensive sun exposure damage, and post-operative breast reconstruction procedures. Those therapies have been pioneered with good results in Europe and Australia, respectively.

Other treatments currently proven or under trial include treatments for traumatic hamstring injury (http://ir.cytori.com/investor-relations/News/news-details/2014/Cytori-to-Initiate-US-Clinical-Trial-of-Adipose-Derived-Regenerative-Cells-in-Hamstring-Injuries/default.aspx) and chronic heart failure (http://www.cytori.com/Innovations/ClinicalTrials/CardiovascularDisease.aspx).

Though much American resistance to stem cell research has been rooted in ethical concerns about the use of embryonic stem cells, the Cytori procedure uses Adipose-Derived Regenerative Cells, or ADRCs stem cells derived from the patients own body fat and altered for re-injection using a proprietary process. Dr. Drehsen was one of a handful of doctors in the United States to use this technology for plastic surgery before the FDA blocked its usage. This makes him one of the most experienced surgeons in the U.S. in non-embryonic stem-cell enhanced facelift procedures. Drehsens website (http://cliniqueps.com) features many examples of his past successful stem-cell procedure outcomes.

The FDA serves the vital function of ensuring patient safety. But these procedures have been proven safe," Drehsen concludes. "It should be no surprise that using a patients own tissue presents fewer risks than many alternatives. Its sad that these options have continued to be blocked by bureaucracy.

Drehsen says that much of the equipment used in his stem cell procedures now sits in storage, unused.

Read the original post:
St. Petersburg Surgeon Dr. Christian Drehsen Lobbies FDA to Speed Approval of Non-Embryonic Stem Cell Therapy

Stem cell scientist Mahendra Rao, former director of the now-defunct Center For Regenerative Medicine at the National Institutes of Health. Photo taken in December, 2013 during a speech by Rao at the World Stem Cell Summit in San Diego.

One of the nation's top stem cell scientists has become an adviser to San Diego's Stemedica, a developer of stem cell-based therapies.

Dr. Mahendra Rao joined Stemedica's scientific and medical advisory board, and will help guide the company's strategy, said Maynard Howe, chief executive of the privately held company. Rao's career as a scientist who has also worked for companies and federal agencies makes him particularly useful, Howe said.

Rao is a medical doctor with a PhD in developmental neurobiology from CalTech. He headed the neurosciences division of the National Institute on Aging. He also led the stem cell division of Carlsbad-based Life Technologies, now a unit of Thermo Fisher Scientific. The two companies are on good terms: Life Technologies sells two kinds of stem cells made by Stemedica, used for research purposes, Howe said.

Rao was most recently founding director of the Center for Regenerative Medicine at the National Institutes of Health, which has been shut down. Rao, who resigned at the end of March, said he was disappointed at the slow pace of funding studies with artificial embryonic stem cells, called induced pluripotent stem cells. Stemedica announced his appointment April 8.

Rao said Wednesday that his goal now is to advance stem cell therapies through the private sector. Stemedica drew his attention because it had developed a method of reliably generating "clinically compliant" stem cells suitable for use in therapy.

In addition, Rao said he likes that Stemedica is developing combination stem cell therapies, using a variety called mesenchymal stem cells. This variety of stem cell generates chemicals that promote short-term regrowth and seems to enhance the survival of other transplanted stem cells. For example, mesenchymal stem cells could help transplanted neural stem cells integrate into the brain.

"That's a high-risk process and it's a much more difficult road, but they seem to be willing to do that," Rao said.

He has also rejoined the board of Q Therapeutics, a Salt Lake City company developing treatments for spinal cord injuries and other neurological disorders. Rao is the company's scientific founder, but had to leave the company when he joined the NIH.

Stemedica and its affiliated companies are undertaking multiple clinical trials of stem cell therapies. One of the most advanced is for stroke, Howe said. See utsandiego.com/stemedicastroke1 for detailed information.

View original post here:
Top stem cell scientist joins Stemedica